Congress Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $118M | Buy |
|
|||||
|
2025
Q2 | $73.7M | Buy |
|
|||||
|
2025
Q1 | $67.6M | Buy |
|
|||||
|
2024
Q4 | $66.6M | Buy |
|
|||||
|
2024
Q3 | $60.5M | Buy |
|
|||||
|
2024
Q2 | $49.4M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $3.09M | Buy |
|
|||||
|
2020
Q2 | $3.46M | Buy |
|
|||||
|
2020
Q1 | $2.2M | Buy |
|
|||||
|
2019
Q4 | $1.99M | Sell |
|
|||||
|
2019
Q3 | $2.54M | Buy |
|
|||||
|
2019
Q2 | $2.74M | Buy |
|
|||||
|
2019
Q1 | $2.81M | Buy |
|
|||||
|
2018
Q4 | $2.9M | Sell |
|
|||||
|
2018
Q3 | $5.88M | Sell |
|
|||||
|
2018
Q2 | $4.53M | Buy |
|
|||||
|
2018
Q1 | $3.44M | Buy |
|
|||||
|
2017
Q4 | $2.55M | Buy |
|
|||||
|
2017
Q3 | $2.02M | Buy |
|
|||||
|
2017
Q2 | $927K | Buy |
|
|||||
|
2017
Q1 | $678K | Buy |
|
|||||
|
2016
Q4 | $456K | Buy |
|